1 Department of Family Medicine, Korea University College of Medicine , Seoul, South Korea .
J Womens Health (Larchmt). 2014 Mar;23(3):267-74. doi: 10.1089/jwh.2013.4497. Epub 2013 Nov 28.
The effects of obesity on the kidney, apart from diabetes or hypertension, have not drawn much attention. Moreover, only a few studies have reported the relationship between obesity status and albuminuria in Asian countries, including South Korea. Therefore, this study aimed to investigate the association between obesity status and albuminuria in Korean adults.
We analyzed data from the 2011 Korea National Health and Nutrition Examination Survey. Of the 4,979 subjects included in the general-population group, 3,274 were sorted into a nondiabetic and nonhypertensive population group. Obesity status was measured by body mass index and waist circumference. Albuminuria was defined as a urine albumin-to-creatinine ratio ≥30 mg/g.
Abdominally obese women were at higher risk for albuminuria than were women without abdominal obesity both in the general population (odds ratio [OR], 95% confidence interval [CI]: 2.08 [1.04-4.16]) and in the nondiabetic and nonhypertensive population (OR [95% CI]: 6.96 [2.34-20.64]) after further adjustment for confounders. Among generally nonobese women, abdominally obese women were at higher risk for albuminuria than were women without abdominal obesity both in the general population (OR [95% CI]: 2.82 [1.51-5.29]) and in the nondiabetic and nonhypertensive population (OR [95% CI]: 5.32 [1.47-19.22]).
Abdominal obesity is associated with an increased risk for albuminuria in Korean women, independently of diabetes or hypertension. Screening for abdominal obesity, especially in women, may therefore provide earlier identification of individuals at risk for developing renal disease and cardiovascular disease, even those who are nondiabetic and nonhypertensive.
除糖尿病或高血压外,肥胖对肾脏的影响尚未引起太多关注。此外,仅有少数研究报告了亚洲国家(包括韩国)肥胖状况与蛋白尿之间的关系。因此,本研究旨在调查韩国成年人肥胖状况与蛋白尿之间的关联。
我们分析了 2011 年韩国国家健康和营养检查调查的数据。在纳入的 4979 名普通人群受试者中,有 3274 名被归入非糖尿病和非高血压人群组。肥胖状况通过体重指数和腰围来衡量。蛋白尿定义为尿白蛋白/肌酐比值≥30mg/g。
在普通人群中(优势比[OR],95%置信区间[CI]:2.08[1.04-4.16])和非糖尿病和非高血压人群中(OR[95%CI]:6.96[2.34-20.64]),与无腹部肥胖的女性相比,腹部肥胖的女性发生蛋白尿的风险更高,且调整混杂因素后,这种关联仍然存在。在一般非肥胖女性中,与无腹部肥胖的女性相比,腹部肥胖的女性发生蛋白尿的风险更高,且调整混杂因素后,这种关联仍然存在,在普通人群中(OR[95%CI]:2.82[1.51-5.29])和非糖尿病和非高血压人群中(OR[95%CI]:5.32[1.47-19.22])均如此。
在韩国女性中,腹部肥胖与蛋白尿风险增加相关,且独立于糖尿病或高血压。因此,筛查腹部肥胖,尤其是在女性中,可能有助于更早地识别出患有肾脏疾病和心血管疾病的高危人群,即使他们是非糖尿病和非高血压患者。